Trial Profile
Phase I trial of CMX-16669 for the treatment of viral infections including cytomegalovirus infections
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 Jun 2015
Price :
$35
*
At a glance
- Drugs CMX 16669 (Primary)
- Indications Cytomegalovirus infections; Viral infections
- Focus Adverse reactions
- 25 Jun 2015 New trial record